Showing results (11-20 of 248) with videos related to
Sort By:
Pageof 25
Journal of Clinical Immunology|March 29, 2012
Type17 T-cells in central nervous system autoimmunity and tumorsHideho Okada, Samia J KhouryExpert Opinion on Biological Therapy|October 6, 2004
Cytokine gene therapy for malignant gliomaHideho Okada, Ian F PollackNeuro-Oncology|October 31, 2015
Principles of immunology and its nuances in the central nervous systemGavin P Dunn, Hideho OkadaJournal of Neuro-Oncology|February 25, 2015
Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trialsDavid A Reardon, Hideho OkadaCancer Immunology, Immunotherapy : CII|June 1, 2014
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cellsAkemi Kosaka, Takayuki Ohkuri, Hideho OkadaJapanese Journal of Clinical Oncology|September 28, 2020
The current state of immunotherapy for primary and secondary brain tumors: similarities and differencesTakahide Nejo, Abigail Mende, Hideho OkadaNeuro-Oncology Practice|October 5, 2020
Introduction to immunotherapy for brain tumor patients: challenges and future perspectivesMegan L Montoya, Noriyuki Kasahara, Hideho OkadaThe International Journal of Biochemistry & Cell Biology|February 11, 2010
MicroRNAs in immune regulation--opportunities for cancer immunotherapyHideho Okada, Gary Kohanbash, Michael T LotzeVaccines|August 29, 2024
Lessons from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can We Fuel the Tumor Microenvironment in Gliomas?Lan Hoc Phung, Takahide Nejo, Hideho OkadaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2018
Immunotherapy of Primary Brain Tumors: Facts and HopesRobin A Buerki, Zinal S Chheda, Hideho OkadaPageof 25